Icon

EMEND (nda021549)- (40MG,80MG,125MG)

APREPITANT MERCK
40MG,80MG,125MG
Yes No
2027-Sep-26 Expired
None None
None No
EMEND ® is a substance P/neurokinin 1 (NK1) receptor antagonist. EMEND capsules is indicated • in combination with other antiemetic agents, in patients 12 years of age and older for prevention of: o acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin o nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC)
3 0 3
Total Other Developers 3
Drugs with Suitability No
40MG ** ** - - 3
80MG ** ** - - 3
125MG ** ** - - 2
NDA Sales Available Total Generic Sales Available
Yes 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** *** *.*. *********** ********** ***** **, *********, - ****, ******** (***) ***
****** ******** ****** ******** *************** ******* *********** **** **. *, *****-*, ****** **** *** *********, ****, ****** ******* ******, ***** (***) ***
****** ******* ********** ************* *.*. *********** ********** **** ***** ****** **********, ***** ** *, *****, *****, ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.